Filing Details
- Accession Number:
- 0001104659-20-106098
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-09-17 16:02:54
- Reporting Period:
- 2020-09-15
- Accepted Time:
- 2020-09-17 16:02:54
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1760542 | Hookipa Pharma Inc. | HOOK | () | XX |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1441261 | Fcpr Vi Capital Sofinnova | C/O Hookipa Pharma Inc., 350 Fifth Avenue, 72Nd Floor, Suite 7240 New York NY 10118 | No | No | Yes | No | |
| 1574139 | Sas Partners Sofinnova | C/O Hookipa Pharma Inc., 350 Fifth Avenue, 72Nd Floor, Suite 7240 New York NY 10118 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2020-09-15 | 32,336 | $12.45 | 3,915,755 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-09-15 | 9,261 | $13.16 | 3,906,494 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- Shares sold pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.01 to $13.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- Sofinnova Partners SAS is the managing company of Sofinnova Capital VI FCPR and disclaims beneficial ownership of these shares except to the extent of its pecuniary interest therein, if any.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.01 to $13.37, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Billionaire Hedge Funds
